Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on ...
TipRanks on MSN
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
Rigel Pharmaceuticals ( ($RIGL) ) has released its Q3 earnings. Here is a breakdown of the information Rigel Pharmaceuticals presented to its ...
Zacks Investment Research on MSN
All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy
Rigel Pharmaceuticals (RIGL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback